Zealand Pharma Chief Medical Officer sells shares worth USD 650,000

Adam Steensberg, Chief Medical Officer and Head of Research and Development at Zealand Pharma, has sold 20,000 shares in the company.
Adam Steensberg, Chief Medical Officer and Head of Research and Development | Photo: Zealand Pharma
Adam Steensberg, Chief Medical Officer and Head of Research and Development | Photo: Zealand Pharma
BY RITZAU FINANS, TRANSLATED BY DANIEL INGEMANN KROIER PEDERSEN

Zealand Pharma’s Head of Research and Development Adam Steensberg has sold shares worth USD 655,000 (DKK 4.1m), the company reports in a statement.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading